Novel Role of Toll-like Receptor 3 in Hepatitis C-associated Glomerulonephritis

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 2006 Jan 27

PMID 16436653

Citations 51

Authors

Markus Wornle

Holger Schmid

Bernhard Banas

Monika Merkle

Anna Henger

Maximilian Roeder

Simone Blattner

Elisabeth Bock

Matthias Kretzler

Hermann-Josef Grone

Detlef Schlondorff

Affiliations

Soon will be listed here.

Abstract

Hepatitis C virus (HCV) infection is frequently complicated by glomerulonephritis with immune complexes containing viral RNA. We examined the potential influence of Toll-like receptors (TLRs), specifically TLR3 recognition of viral dsRNA exemplified by polyriboinosinic:polyribocytidylic acid [poly(I:C) RNA]. Normal human kidney stained positive for TLR3 on mesangial cells (MCs), vascular smooth muscle cells, and collecting duct epithelium. Cultured MCs have low TLR3 mRNA levels with predominant intracellular protein localization, which was increased by tumor necrosis factor-alpha, interleukin (IL)-1beta, interferon (IFN)-gamma, and the TLR3 ligand poly(I:C) RNA. Poly(I:C) RNA stimulation of MCs increased mRNA and protein synthesis of IL-6, IL-1beta, M-CSF, IL-8/CXCL8, RANTES/CCL5, MCP-1/CCL2, and ICAM-I; it also increased anti-proliferative and proapoptotic effects, the latter of which was decreased by inhibiting caspase-8. In microdissected glomeruli of normal and non-HCV membranoproliferative glomerulonephritis biopsies, TLR3 mRNA expression was low. In contrast TLR3 mRNA expression was significantly increased in hepatitis C-positive glomerulonephritis and was associated with enhanced mRNA for RANTES/CCL5 and MCP-1/CCL2. We hypothesize that immune complexes containing viral RNA activate mesangial TLR3 during HCV infection, thereby contributing to chemokine/cytokine release and effecting proliferation and apoptosis. Thus, TLR3 expression on renal cells, and especially MCs, may establish a link between viral infections and glomerular diseases.

Citing Articles

Metabolic disorders induced by PNPLA3 and TM6SF2 gene variants affect chronic kidney disease in patients infected with non-genotype 3 hepatitis C virus.

Liu J, Qi W, Wang S, Zhang Y, Wang X, Sun D Lipids Health Dis. 2023; 22(1):91.

PMID: 37400794 PMC: 10316563. DOI: 10.1186/s12944-023-01858-4.

Toll-like Receptor 9 Induced Dendritic Cell Activation Promotes Anti-Myeloperoxidase Autoimmunity and Glomerulonephritis.

Ford S, OSullivan K, Kitching A, Holdsworth S, Gan P, Summers S Int J Mol Sci. 2023; 24(2).

PMID: 36674855 PMC: 9864438. DOI: 10.3390/ijms24021339.

Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis C Virus Infection.

Songtanin B, Nugent K Biology (Basel). 2023; 12(1).

PMID: 36671716 PMC: 9855523. DOI: 10.3390/biology12010023.

Exploring the Underlying Mechanism of Shenyankangfu Tablet in the Treatment of Glomerulonephritis Through Network Pharmacology, Machine Learning, Molecular Docking, and Experimental Validation.

Jin M, Ren W, Zhang W, Liu L, Yin Z, Li D Drug Des Devel Ther. 2021; 15:4585-4601.

PMID: 34785888 PMC: 8590514. DOI: 10.2147/DDDT.S333209.

Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

McSweeney K, Kate Gadanec L, Qaradakhi T, Ali B, Zulli A, Apostolopoulos V Cancers (Basel). 2021; 13(7).

PMID: 33805488 PMC: 8036620. DOI: 10.3390/cancers13071572.

References

Meyers C, Seeff L, Stehman-Breen C, Hoofnagle J . Hepatitis C and renal disease: an update. Am J Kidney Dis. 2003; 42(4):631-57. DOI: 10.1016/s0272-6386(03)00828-x. View

Medzhitov R, Janeway Jr C . Innate immunity: the virtues of a nonclonal system of recognition. Cell. 1997; 91(3):295-8. DOI: 10.1016/s0092-8674(00)80412-2. View

Uchiyama-Tanaka Y, Mori Y, Kishimoto N, Nose A, Kijima Y, Nagata T . Membranous glomerulonephritis associated with hepatitis C virus infection: case report and literature review. Clin Nephrol. 2004; 61(2):144-50. DOI: 10.5414/cnp61144. View

Zhang D, Zhang G, Hayden M, Greenblatt M, Bussey C, Flavell R . A toll-like receptor that prevents infection by uropathogenic bacteria. Science. 2004; 303(5663):1522-6. DOI: 10.1126/science.1094351. View

Anders H, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez De Lema G . Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J. 2004; 18(3):534-6. DOI: 10.1096/fj.03-0646fje. View

Matsumoto M, Funami K, Oshiumi H, Seya T . Toll-like receptor 3: a link between toll-like receptor, interferon and viruses. Microbiol Immunol. 2004; 48(3):147-54. DOI: 10.1111/j.1348-0421.2004.tb03500.x. View

Anders H, Banas B, Schlondorff D . Signaling danger: toll-like receptors and their potential roles in kidney disease. J Am Soc Nephrol. 2004; 15(4):854-67. DOI: 10.1097/01.asn.0000121781.89599.16. View

Timoshanko J, Kitching A, Iwakura Y, Holdsworth S, Tipping P . Contributions of IL-1beta and IL-1alpha to crescentic glomerulonephritis in mice. J Am Soc Nephrol. 2004; 15(4):910-8. DOI: 10.1097/01.asn.0000115704.86897.f4. View

Barton G, Medzhitov R . Toll signaling: RIPping off the TNF pathway. Nat Immunol. 2004; 5(5):472-4. DOI: 10.1038/ni0504-472. View

10.

Yang E, Shin J, Kim H, Park H, Kim M, Kim S . Cloning of TLR3 isoform. Yonsei Med J. 2004; 45(2):359-61. DOI: 10.3349/ymj.2004.45.2.359. View

11.

Kessler N, Ferraris O, Palmer K, Marsh W, Steel A . Use of the DNA flow-thru chip, a three-dimensional biochip, for typing and subtyping of influenza viruses. J Clin Microbiol. 2004; 42(5):2173-85. PMC: 404638. DOI: 10.1128/JCM.42.5.2173-2185.2004. View

12.

Porubsky S, Schmid H, Bonrouhi M, Kretzler M, Malle E, Nelson P . Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium. Am J Pathol. 2004; 164(6):2175-87. PMC: 1615757. DOI: 10.1016/S0002-9440(10)63775-3. View

13.

Niemir Z, Stein H, Ciechanowicz A, Olejniczak P, Dworacki G, Ritz E . The in situ expression of interleukin-8 in the normal human kidney and in different morphological forms of glomerulonephritis. Am J Kidney Dis. 2004; 43(6):983-98. DOI: 10.1053/j.ajkd.2004.02.011. View

14.

Zhang J, Xu L, Han K, Wei X, Shu H . PIASy represses TRIF-induced ISRE and NF-kappaB activation but not apoptosis. FEBS Lett. 2004; 570(1-3):97-101. DOI: 10.1016/j.febslet.2004.05.081. View

15.

Hughes J, Cailhier J, Watson S, Savill J . Apoptosis in glomerulonephritis. Rheum Dis Clin North Am. 2004; 30(3):655-76, xi-xii. DOI: 10.1016/j.rdc.2004.04.004. View

16.

Lenda D, Stanley E, Kelley V . Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice. J Immunol. 2004; 173(7):4744-54. DOI: 10.4049/jimmunol.173.7.4744. View

17.

Heeg K, Reimann J, Kabelitz D, Hardt C, Wagner H . A rapid colorimetric assay for the determination of IL-2-producing helper T cell frequencies. J Immunol Methods. 1985; 77(2):237-46. DOI: 10.1016/0022-1759(85)90036-5. View

18.

Fukatsu A, Matsuo S, Tamai H, Sakamoto N, Matsuda T, Hirano T . Distribution of interleukin-6 in normal and diseased human kidney. Lab Invest. 1991; 65(1):61-6. View

19.

Brown Z, Strieter R, Chensue S, Ceska M, Lindley I, Neild G . Cytokine-activated human mesangial cells generate the neutrophil chemoattractant, interleukin 8. Kidney Int. 1991; 40(1):86-90. DOI: 10.1038/ki.1991.184. View

20.

Hora K, Satriano J, Santiago A, Mori T, Stanley E, Shan Z . Receptors for IgG complexes activate synthesis of monocyte chemoattractant peptide 1 and colony-stimulating factor 1. Proc Natl Acad Sci U S A. 1992; 89(5):1745-9. PMC: 48529. DOI: 10.1073/pnas.89.5.1745. View